Received: 21 May 2019
Accepted: 29 October 2019
First Online: 15 November 2019
Ethics approval and consent to participate
: The research design was reviewed and approved the Ethics Committee of China Pharmaceutical University, Nanjing city, Jangsu Province, China (Project Number: CPU2014006).Written consent to participate was signed by all participated pharmacy students.
: Not applicable.
: The authors declare that they have no competing interests.